Nokia 710 User Manual page 15

one gram of tissue. The highest SAR value reported under this standard during product certification for use at the ear is
1.15 W/kg and when properly worn on the body is 1.18 W/kg .
Message from the FDA
The U.S. Food and Drug Administration (FDA) provides the following consumer information about wireless phones.
See http://www.fda.gov/cellphones for updated information.
Do wireless phones pose a health hazard?
The available scientific evidence does not show that any health problems are associated with using wireless phones. There
is no proof, however, that wireless phones are absolutely safe. Wireless phones emit low levels of radiofrequency energy
(RF) in the microwave range while being used. They also emit very low levels of RF when in the stand-by mode. Whereas high
levels of RF can produce health effects (by heating tissue), exposure to low level RF that does not produce heating effects
causes no known adverse health effects. Many studies of low level RF exposures have not found any biological effects. Some
studies have suggested that some biological effects may occur, but such findings have not been confirmed by additional
research. In some cases, other researchers have had difficulty in reproducing those studies, or in determining the reasons
for inconsistent results.
What is the FDA's role concerning the safety of wireless phones?
Under the law, FDA does not review the safety of radiation-emitting consumer products such as wireless phones before
they can be sold, as it does with new drugs or medical devices. However, the agency has authority to take action if wireless
phones are shown to emit radiofrequency energy (RF) at a level that is hazardous to the user. In such a case, FDA could
require the manufacturers of wireless phones to notify users of the health hazard and to repair, replace or recall the phones
so that the hazard no longer exists.
Although the existing scientific data do not justify FDA regulatory actions, FDA has urged the wireless phone industry to
take a number of steps, including the following:
•
Support needed research into possible biological effects of RF of the type emitted by wireless phones;
•
Design wireless phones in a way that minimizes any RF exposure to the user that is not necessary for device function;
and
•
Cooperate in providing users of wireless phones with the best possible information on possible effects of wireless
phone use on human health.
FDA belongs to an interagency working group of the federal agencies that have responsibility for different aspects of RF
safety to ensure coordinated efforts at the federal level. The following agencies belong to this working group:
•
National Institute for Occupational Safety and Health
•
Environmental Protection Agency
•
Federal Communications Commission
•
Occupational Safety and Health Administration
•
National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency working group activities, as well.
FDA shares regulatory responsibilities for wireless phones with the Federal Communications Commission (FCC). All phones
that are sold in the United States must comply with FCC safety guidelines that limit RF exposure. FCC relies on FDA and
other health agencies for safety questions about wireless phones.
FCC also regulates the base stations that the wireless phone networks rely upon. While these base stations operate at higher
power than do the wireless phones themselves, the RF exposures that people get from these base stations are typically
thousands of times lower than those they can get from wireless phones. Base stations are thus not the primary subject of
the safety questions discussed in this document.
Product and safety information 15